Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Fox Run Management L.L.C.

Fox Run Management L.L.C. increased its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 172.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,835 shares of the biotechnology company’s stock after purchasing an additional 1,796 shares during the period. Fox Run Management L.L.C.’s holdings in Axon Enterprise were worth $1,685,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Asset Dedication LLC grew its holdings in shares of Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after purchasing an additional 18 shares during the period. Bleakley Financial Group LLC boosted its holdings in Axon Enterprise by 1.3% in the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after purchasing an additional 20 shares during the last quarter. Venturi Wealth Management LLC grew its stake in shares of Axon Enterprise by 2.7% in the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock valued at $477,000 after buying an additional 21 shares during the period. Insigneo Advisory Services LLC increased its holdings in shares of Axon Enterprise by 1.4% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after buying an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC raised its position in shares of Axon Enterprise by 0.8% during the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after buying an additional 24 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares of the company’s stock, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,792 shares of company stock worth $1,087,843. Corporate insiders own 5.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on AXON shares. Needham & Company LLC reiterated a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 26th. The Goldman Sachs Group increased their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Barclays restated a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. TD Cowen initiated coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price for the company. Finally, JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $604.67.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $560.00 on Friday. The company’s 50 day moving average is $591.90 and its two-hundred day moving average is $540.96. The firm has a market cap of $42.91 billion, a PE ratio of 144.70, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.